CPEX recommends shareholders to take no action on Arcadia's unsolicited tender offer

NewsGuard 100/100 Score
Editorial Checklist Reviewed
Apr 24 2010CPEX Pharmaceuticals, Inc.

The Board of Directors of CPEX Pharmaceuticals Inc., (NASDAQ: CPEX) today recommended that its shareholders take no action at this time in response to the announcement by Arcadia Capital Advisors, LLC through RSR Acquisition Co. and its principal Richard Rofé that it has made an unsolicited conditional tender offer to acquire all of the outstanding shares of CPEX for $16.00 per share in cash.

Consistent with its fiduciary duties and in consultation with its financial and legal advisors, the CPEX Board will review and consider Arcadia's offer, and within 10 business days, will advise CPEX's shareholders of the Board's position regarding the tender offer as well as its reasons for that position.

RBC Capital Markets Corporation is acting as financial advisor to CPEX and Goodwin Procter LLP is acting as legal advisor.

Source:

CPEX Pharmaceuticals, Inc.

Posted in:

Tags: , , ,

Comments (0)

Suggested Reading

Study highlights global fertility decline and its implications for the future
Lancet Commission predicts sharp increase in global prostate cancer cases
Georgetown study raises concerns over aspirin's role in breast cancer treatment
New urine-based test improves identification of high-grade prostate cancer
Lab to plant: Scaling up API processes with Dr. James Mencel's guidance
Pembrolizumab enhances breast cancer treatment regardless of age or menopausal status
St. Jude researchers unveil mechanisms to block PXR and enhance drug potency
Extended CPAP treatment boosts lung development in premature infants

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Natural obesity fighters: How coffee, tea, and cocoa combat weight gain